• PDA TR 63

PDA TR 63

  • Technical Report No. 63 (TR 63) Quality Requirements for the Extemporaneous Preparation of Clinical Trial Materials
  • Report / Survey by Parenteral Drug Association, 09/01/2013
  • Category: PDA

$325.00 $163.00

A recent benchmarking exercise conducted by the PDA Quality Requirements for the Extemporaneous Preparation of Clinical Trial Materials Technical Report Team indicates that extemporaneous preparation (EP) techniques are widely used to prepare a variety of formulations for a variety of dosage forms for small-scale clinical studies where dosing is in-clinic. Since the quality requirements for dose preparation activities that occur at clinical sites are not always clear, this gap becomes very important as investigators are increasingly using EP to support small-scale clinical studies. While traditional CGMP systems may not be in place in such areas, there still must be appropriate controls in place to ensure patient safety. Technical Report No. 63: Quality Requirements for the Extemporaneous Preparation of Clinical Trial Materials describes a quality system that will support the preparation of clinical trial materials in a nonmanufacturing environment in a manner that will ensure product quality and patient safety.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 63

PDA TR 63

Technical Report No. 63 (TR 63) Quality Requirements for the Extemporaneous Preparation of Clinical ..

$163.00 $325.00

PDA TR 33

PDA TR 33

Technical Report 33, Revised 2013 (TR 33) Evaluation, Validation and Implementation of Alternative a..

$163.00 $325.00

PDA TR 64

PDA TR 64

Technical Report No. 64 (TR 64) Active Temperature-Controlled Systems: Qualification Guidance..

$163.00 $325.00

PDA TR 54-3

PDA TR 54-3

Technical Report No. 54-3 (TR 54-3) Implementation of Quality Risk Management for Pharmaceutical and..

$163.00 $325.00